A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

NCT00281606 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Different formulations of once-daily lopinavir/ritonavir

Sponsor

University of California, San Diego

Collaborators

[object Object]